Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
Abstract Cancer vaccines are less effective at old than at young age because of immunosenescence. Besides, in preliminary observations we showed that the immunization with HER-2/neu DNA plasmid in transgenic young mice (standard immunization, SI) delays but not abrogate spontaneous mammary tumours p...
Guardado en:
Autores principales: | Mauro Provinciali, Alessandra Barucca, Fiorenza Orlando, Elisa Pierpaoli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30a26d3f0af04239af09033dd04f3b15 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
por: Maral Mokhtari, et al.
Publicado: (2021) -
Cancer biomarker HER-2/neu in breast cancer in Indian women
por: Singhai R, et al.
Publicado: (2011) -
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
por: Salkeni MA, et al.
Publicado: (2021) -
Antiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoediting
por: Matthew M Seavey, et al.
Publicado: (2009) -
Applicability and interpretation of HER2/Neu & PD-L1 stains in gastrointestinal tract tumours
por: Prasenjit Das, et al.
Publicado: (2021)